Closing Session

Thu, Mar 20, 2025 · 2:30–3:45 PM CET San Francisco Room, Congress Center Basel

Speakers

Lada Leyens

Senior Director regulatory · Takeda

Speaker
Monique Al

Special advisor sr · CCMO, Then Netherlands

Speaker
Sarah Pope Miksinski

Executive Director, CMC Regulatory Affairs · Gilead Sciences

Speaker
Mark Pellett

Executive Director · AstraZeneca

Speaker
Gracy Crane

Policy Lead · Roche

Speaker
Estelle Michael

Policy and public affairs lead · UCB

Speaker
Claudia Dollins

Vice President, Precision Medicines, Global Regulatory Affairs · GlaxoSmithKline

Speaker
Thomas Wejs Møller

Senior Director · Novo Nordisk

Speaker
Sebastian Fischer

Regulatory Strategy Principal · TÜV SÜD Product Service GmbH

Speaker
Sabina Hoekstra-van den Bosch

Global Director Regulatory Strategy · TÜV SÜD

Speaker
Wim van der Spuij

Executive Director, International Patient Safety, Europe · Bristol Myers Squibb

Speaker
James Whitehead

Head of Patient Safety · Egetis Therapeutics

Speaker
Tim Powell

Director, Submission Sciences, Global Safety and Regulatory Sciences · Biogen

Speaker
Kate Porch

Director, elabeling Lead, Global Labeling, Global Regulatory Affairs · Johnson & Johnson

Speaker
Rebecca Lumsden

Head of Regulatory Science & Policy, Europe · Sanofi

Speaker
Tamara Di Carlantonio

Regulatory Policy Lead · Roche

Speaker
Inka Heikkinen

Regulatory Policy Lead, Director · Lundbeck

Speaker
Kostas Papadakis

Global Head of Oncology Market Access (International) · Bayer

Speaker
Sara Torgal

Global Regulatory Policy Leader (EMEA) · DIA

Chair